Clinical Trial Update: Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 trial update on piperacillin/tazobactam in critically ill patients with severe sepsis and septic shock; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Sutep Jaruratanasirikul | Conditions: Early Phase of Severe Sepsis and Septic Shock | Phase 4 | Status: COMPLETED